Regenerative Therapy for CLI: STOP-PAD Trial - Mehdi H. Shishehbor, DO, PhD

Phoenix Atherectomy – Why, When, and How? - Mehdi H. Shishehbor, DO, PhDПодробнее

Perfusion Assessment in CLI - Mehdi H. Shishehbor, DO, PhDПодробнее

The Impact of CMS, MEDCAC & the ACA on PAD and CLI Management - Mehdi H. Shishehbor, DO, PhDПодробнее

Alternative Access – Why, When - Mehdi H. Shishehbor, DO, PhDПодробнее

CVI2018 Session: Innovation in PAD and CLI (Aspen Ballroom, July 26, 1:30 pm)Подробнее

Segmentalized Approach to Femoropopliteal Intervention - Mehdi H. Shishehbor, DO, PhDПодробнее

CVI2018 Session: Role of biologic therapies - Mehdi Shishehbor, DO, MPH, PhDПодробнее

VEITH 22: Findings From the BEST-CLI Trial | Dr Farber, Dr Rosenfield & Dr MenardПодробнее

Guidelines For Testing PAD Patients For CAD I Dr Mehdi ShishehborПодробнее

CVI2018 Session: DCB, DES, wire interwoven, or covered stents - Mehdi Shishehbor, DO, MPH, PhDПодробнее

The future of regenerative medicine in transplantationПодробнее

Run Away from Surgery and Towards Regenerative Stem Cell TherapyПодробнее

Regenerative Therapy - PRP for Ligament & Tissue RepairПодробнее

ANCHOR Study: ESAR is More than Reinforced Proximal Seal | Prof Michel ReijnenПодробнее